Literature DB >> 18544581

Fecundability and spontaneous abortions in women with self-reported oligo-amenorrhea and/or hirsutism: Northern Finland Birth Cohort 1966 Study.

R Koivunen1, A Pouta, S Franks, H Martikainen, U Sovio, A-L Hartikainen, M I McCarthy, A Ruokonen, A Bloigu, M-R Järvelin, L Morin-Papunen.   

Abstract

BACKGROUND: Women with polycystic ovary syndrome (PCOS) suffer from anovulatory infertility and hospital-based studies suggest that they have an increased risk of spontaneous abortion. Our aim was to investigate the proportion of women, with self-reported oligo-amenorrhea and/or hirsutism in a general population, who had suffered from infertility, the percentage of them managing to conceive and their rate of spontaneous abortion.
METHODS: At age 31, a postal questionnaire including questions about hirsutism and oligo-amenorrhea was sent to all women from the population-based Northern Finland Birth Cohort 1966 (total n = 5889). Of these, 4535 (79.5%) answered the questionnaire, 1103 reported hirsutism and/or oligo/amenorrhea (symptomatic women) and 3420 were non-symptomatic. The fecundability ratio (FR) was defined as the probability of conception of a clinically detectable pregnancy within 12 months.
RESULTS: The overall pregnancy (77.7% versus 75.6%) and spontaneous abortion (19.3% versus 18.6%) rates did not differ between the two groups and the risk of spontaneous abortion was not associated with body mass index (BMI), waist-to-hip ratio (WHR) or waist circumference. Symptomatic women had suffered more often from infertility than non-symptomatic women (19.4% versus 11.1%, P < 0.01). Oligo-amenorrhea and/or hirsutism (FR = 0.74, P < 0.001) and obesity (FR = 0.68, P = 0.002) were both independently associated with decreased fecundability, but symptomatic women had become pregnant and had one or two successful deliveries as often as non-symptomatic women.
CONCLUSIONS: Women with self-reported oligo-amenorrhea and/or hirsutism had lower fecundability and suffered more often from infertility, but had at least one delivery as often as non-symptomatic women, and did not exhibit an increased risk of spontaneous abortion.

Entities:  

Mesh:

Year:  2008        PMID: 18544581     DOI: 10.1093/humrep/den136

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  19 in total

Review 1.  Fertility treatment in women with polycystic ovary syndrome: a decision analysis of different oral ovulation induction agents.

Authors:  Emily S Jungheim; Anthony O Odibo
Journal:  Fertil Steril       Date:  2010-05-07       Impact factor: 7.329

2.  Mesenchymal stem/progenitors and other endometrial cell types from women with polycystic ovary syndrome (PCOS) display inflammatory and oncogenic potential.

Authors:  T T Piltonen; J Chen; D W Erikson; T L B Spitzer; F Barragan; J T Rabban; H Huddleston; J C Irwin; L C Giudice
Journal:  J Clin Endocrinol Metab       Date:  2013-07-03       Impact factor: 5.958

3.  Association of testosterone and antimüllerian hormone with time to pregnancy and pregnancy loss in fecund women attempting pregnancy.

Authors:  Lindsey A Sjaarda; Sunni L Mumford; Daniel L Kuhr; Tiffany L Holland; Robert M Silver; Torie C Plowden; Neil J Perkins; Enrique F Schisterman
Journal:  Fertil Steril       Date:  2018-02-07       Impact factor: 7.329

4.  Altered microRNA and gene expression in the follicular fluid of women with polycystic ovary syndrome.

Authors:  Lauren W Roth; Blair McCallie; Ruben Alvero; William B Schoolcraft; Debra Minjarez; Mandy G Katz-Jaffe
Journal:  J Assist Reprod Genet       Date:  2014-01-04       Impact factor: 3.412

5.  Menstrual irregularity and cardiovascular mortality.

Authors:  Erica T Wang; Piera M Cirillo; Eric Vittinghoff; Kirsten Bibbins-Domingo; Barbara A Cohn; Marcelle I Cedars
Journal:  J Clin Endocrinol Metab       Date:  2010-10-27       Impact factor: 5.958

6.  Metabolic and carbohydrate characteristics of different phenotypes of polycystic ovary syndrome.

Authors:  Ebru Çelik; Ilgın Türkçüoğlu; Barış Ata; Abdullah Karaer; Pınar Kırıcı; Sevil Eraslan; Çağatay Taşkapan; Bülent Berker
Journal:  J Turk Ger Gynecol Assoc       Date:  2016-12-01

Review 7.  Ontogeny of the ovary in polycystic ovary syndrome.

Authors:  Daniel A Dumesic; Joanne S Richards
Journal:  Fertil Steril       Date:  2013-03-06       Impact factor: 7.329

8.  Irregular menstruation and hyperandrogenaemia in adolescence are associated with polycystic ovary syndrome and infertility in later life: Northern Finland Birth Cohort 1986 study.

Authors:  S West; H Lashen; A Bloigu; S Franks; K Puukka; A Ruokonen; M-R Järvelin; J S Tapanainen; L Morin-Papunen
Journal:  Hum Reprod       Date:  2014-08-01       Impact factor: 6.918

9.  A comparison of IVF outcomes transferring a single ideal blastocyst in women with polycystic ovary syndrome and normal ovulatory controls.

Authors:  Naama Steiner; Senem Ates; Talya Shaulov; Guy Shrem; Alexander Volodarsky-Perel; S Yehuda Dahan; Samer Tannus; Weon-Young Son; Michael H Dahan
Journal:  Arch Gynecol Obstet       Date:  2020-07-15       Impact factor: 2.344

10.  Predictors of pregnancy in women with polycystic ovary syndrome.

Authors:  Mary E Rausch; Richard S Legro; Huiman X Barnhart; William D Schlaff; Bruce R Carr; Michael P Diamond; Sandra A Carson; Michael P Steinkampf; Peter G McGovern; Nicholas A Cataldo; Gabriella G Gosman; John E Nestler; Linda C Giudice; Phyllis C Leppert; Evan R Myers; Christos Coutifaris
Journal:  J Clin Endocrinol Metab       Date:  2009-06-09       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.